OP0111 Tocilizumab discontinuation after attaining remission in patients with rheumatoid arthritis who were treated with tocilizumab alone or in combination with methotrexate: results from a prospective, randomised, controlled study (THE SECOND YEAR OF THE SURPRISE STUDY)
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.